QGA
LSBPW

Q Global Advisors’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Q Global Advisors’s Portfolio LSBPW Stock Details LSBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-130,600
Closed -$5K – 49
2025
Q2 		$5K Hold
130,600
– – ﹤0.01% 41
2025
Q1 		$5K Hold
130,600
– – ﹤0.01% 40
2024
Q4 		$10K Hold
130,600
– – 0.01% 35
2024
Q3 		$9K Hold
130,600
– – 0.01% 30
2024
Q2 		$11K Hold
130,600
– – 0.01% 48
2024
Q1 		$9K Hold
130,600
– – ﹤0.01% 73
2023
Q4 		$5K Hold
130,600
– – ﹤0.01% 64
2023
Q3 		$5K Hold
130,600
– – ﹤0.01% 107
2023
Q2 		$6K Hold
130,600
– – ﹤0.01% 107
2023
Q1 		$20K Buy
+130,600
New +$19.8K 0.01% 44

Other funds holding LSBPW

HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Q Global Advisors's LSBPW Position: Q3 2025 in Review

Q Global Advisors sold out of LakeShore Biopharma Warrants (LSBPW) in Q3 2025, closing a stake of 130,600 shares — an estimated $5K sold.

Q Global Advisors first reported a position in LSBPW in Q1 2023 and held it in 10 quarters. The position peaked at $20K in Q1 2023. 3 funds tracked by Wall St. Rank hold LSBPW as of Q3 2025.

  • Q Global Advisors reported no remaining LakeShore Biopharma Warrants position as of Q3 2025 after selling out during the quarter.
  • Q Global Advisors sold 130,600 LakeShore Biopharma Warrants shares in Q3 2025, an estimated $5K.
  • Q Global Advisors first reported a position in LakeShore Biopharma Warrants in Q1 2023 and held it in 10 quarters.
  • Q Global Advisors's LakeShore Biopharma Warrants position peaked at $20K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q3 2025.

Based on Q Global Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.